Biopharma News : Biopharma and Pharma news from all around the world :
- Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2020 Financial Results
- AbCellera Files Patent Infringement Lawsuit Against Berkeley Lights, Inc.
- Answering Key Questions on Pharmaceutical Logistics | Gain access to Infiniti’s Research’s thought leader insights
- Vizient Urges CMS to Reduce Burdens in IPPS Comment Letter
- AI Can Help COVID-19 Clinical Decision Making, Feinstein Institutes Research Shows
- Outlook on the Obstructive Sleep Apnea Global Market (2020 to 2024) – Develop Tactics and Strategies to Take Advantage of Opportunities – ResearchAndMarkets.com
- Worldwide Cystic Fibrosis Industry to 2024 – Develop In-Depth Knowledge of Competition and Markets – ResearchAndMarkets.com
- Half Year Median Technologies Liquidity Contract Statement Contracted with Louis Capital Markets UK LLP
- Enhancing Operations and Savings for a Pharma Secondary Packaging Market Client | Impact of Infiniti Research’s Competitive Intelligence Solutions
- Company Profile for Reven, LLC
- ITM and RadioMedix announce Drug Master File Submission for ITM’s 68Ge/68Ga Generator GeGant® for the U.S. Market
- GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19
- Rite Aid Announces Early Results and Increase in the Maximum Amount and Exchange Consideration of its Previously Announced Exchange Offer and Related Consent Solicitation
- Modernizing Medicine to Host Must-Attend Event on COVID-19 Vaccine Timeline and Contact Tracing with Special Guest Jerome Kim, MD
- scPharmaceuticals Appoints Sara Bonstein to Board of Directors
- Amneal Launches Generic Fluphenazine Following ANDA Approval by FDA
- Tyme Technologies Announces Virtual 2020 Annual Meeting of Stockholders
- Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program
- Global Nonalcoholic Steatohepatitis Market to 2024 – Synthesize Insights for Business Development & Licensing – ResearchAndMarkets.com
- Organic Skincare Products Market Analysis Highlights the Impact of COVID-19 2020-2024 | Shift Towards Green Cosmeceuticals to boost the Market Growth | Technavio
- MCT Oil Market Analysis Highlights the Impact of COVID-19 2020-2024| Demand for Natural Products to boost the Market Growth | Technavio
- efficacyAI Signs Exclusive Software License for MedicascyAI™ a Suite of Deep Learning Algorithms Used to Predict Drug Safety and Efficacy
- Global Bio-MEMS Devices Market Analysis Highlights the Impact of COVID-19 (2020-2024)| Growing Geriatric Population to Boost Market Growth | Technavio
- Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA) for the Treatment of Spasticity in Children
- Bioasis and Chiesi Group to Host Webcast on July 16, 2020
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Merck Animal Health Receives U.S. FDA Approval of BRAVECTO® (fluralaner) Monthly Chews
- Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund
- Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. ET on August 5, 2020
Biotech – Biopharma News!
- AEVIS VICTORIA SA: Subsidiary Swiss Hotel Properties SA focuses on luxury hospitality real estate
- M1 Kliniken AG: Successfully conducts the annual general meeting. Despite temporary losses due to the lock-down, the Management Board confirms its assessment of the company’s growth prospects.
- RHÖN-KLINIKUM Aktiengesellschaft: Management Board of RHÖN-KLINIKUM AG Welcomes New Partnership with Asklepios
- RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020
- Asklepios Kliniken: Asklepios successfully acquires RHÖN-KLINIKUM AG
- Heidelberg Pharma AG: Heidelberg Pharma reports on first half-year 2020
- PAION REPORTS FULL CONVERSION OF CONVERTIBLE NOTES
- Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care holds virtual General Meeting on August 27, 2020 – dividend proposal unchanged
- Medios AG: Additional production site enables tripling of production capacities
- APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
- EVOTEC INITIATES ‘CAMPUS CURIE’ IN TOULOUSE
- B.R.A.I.N. Biotechnology Research And Information Network AG: Change in the Management Board of BRAIN AG – Chief Business Officer Ludger Roedder is leaving the executive board with immediate effect
- Molecular Partners AG: Molecular Partners Successfully Completes the Launch of a Private Placement of 5,528,089 Shares by way of an Accelerated Bookbuilding
- Beiersdorf Aktiengesellschaft: Impact of the coronavirus pandemic on sales performance in the first half of 2020
- PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVO) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
- PAION ANNOUNCES U.S. FDA APPROVAL OF REMIMAZOLAM (BYFAVOTM) FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION
- B.R.A.I.N. AG purchases the outstanding 24.7% minority stake of WeissBioTech GmbH
- Xlife Sciences AG: Project company inflamed pharma GmbH obtains grant for COVID-19 project covering 70% of funding
- Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
- Xlife Sciences AG: Xlife Sciences waives early redemption of the privately placed convertible bond until July 1, 2023
- Xlife Sciences AG: Xlife Sciences shares traded on XETRA
- Annual financial statements 2019: 9% sales growth and strongly improved EBITDA; significant milestones and growing interest in pioneering key technologies antibacterial silver coating and resorbable magnesium implants
- curasan AG: curasan AG postpones annual financial report 2019 to 31 July 2020
- Original-Research: MPH Health Care (von First Berlin Equity Research GmbH)
- MagForce AG Publishes Financial Results for the Year 2019 and Operative Highlights (news with additional features)
- aap Implantate AG: Refusal of audit opinions for annual financial report 2019 (HGB) and consolidated annual financial report 2019 (IFRS); implementation of various financing and cost-saving options to secure financing
- CENTOGENE, Lufthansa, and Fraport Launch the First Walk-In COVID-19 Testing Facility in Germany at Frankfurt Airport
- Vivoryon Therapeutics AG: Vivoryon Therapeutics Provides Update on US and EU Alzheimer’s Clinical Trial Program with PQ912
- Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group
- curasan AG: curasan AG and Donau Invest, Vienna, agree on a restructuring concept by an insolvency plan
- MPX International Announces Second Quarter 2020 Financial Results
- Monthly information on share capital and company voting rights
- Avricore Health Completes Shares for Debt Transaction
- Adamas Announces New Employment Inducement Grant
- GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
- Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Vir Biotechnology Appoints Elliott Sigal, M.D., Ph.D. to Board of Directors
- National Lipid Association Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
- Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020
- Tauriga Sciences, Inc. Completes Payment for the Entirety of its Initial Production Run of its Pear Bellini Flavor Immune Booster Tauri-Gum Version
- The Jacobs Center Embraces Virtual Consultations
- The Dermatology Office in Dallas Welcomes Back Patients
- DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology
- Generex Biotechnology Announces Corporate Update and Investor Conference Call: NuGenerex Immuno-Oncology Today Friday July 10, 2020 at 4:15 PM
- Tauriga Sciences, Inc. Chief Executive Officer Seth M. Shaw Completes Insider Purchase — 700,000 Shares @ $0.05 per Share
- Inventiva announces trading resumption of its ordinary shares on Euronext Paris
- Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA
- Nicox Partner Ocumension Completes Successful Hong Kong IPO at an approximately US$1,090 Million Valuation
- Atox Bio Announces a Positive Effect of Reltecimod on Resolution of Organ Dysfunction in Phase 3 ACCUTE Trial for Patients with Necrotizing Soft Tissue Infection (“Flesh Eating Disease”)
- Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
- Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
- Nicox Strengthens Cash Position With Divestment of its VISUfarma Shareholding
- Basilea announces the start of the offer period of its partial repurchase offer for its outstanding convertible bonds due 2022
- Nkarta Announces Pricing of Initial Public Offering
- Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2020
- CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares
- MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
- Health Catalyst Announces Agreement to Acquire healthfinch, a Healthcare IT Company that has Helped Define the Clinical Workflow Optimization Space with its Award-Winning Software
- Cronos Group Announces Completion of Continuance to British Columbia
- CooperCompanies Declares Cash Dividend
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News